Nedbank Group Limited (JSE:NED)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc | Market Cap | 120.62B +5.3% |
| Revenue (ttm) | 59.94B -7.8% |
| Net Income | 7.80B -53.7% |
| EPS | 16.45 -53.2% |
| Shares Out | 456.90M |
| PE Ratio | 16.05 |
| Forward PE | 6.96 |
| Dividend | 21.32 (8.08%) |
| Ex-Dividend Date | Apr 8, 2026 |
| Volume | 885,941 |
| Average Volume | 1,545,928 |
| Open | 26,351 |
| Previous Close | 26,535 |
| Day's Range | 26,246 - 26,664 |
| 52-Week Range | 20,606 - 31,839 |
| Beta | 0.52 |
| RSI | 41.01 |
| Earnings Date | Mar 3, 2026 |
About Nedbank Group
Nedbank Group Limited, together with its subsidiaries, provides various wholesale and retail banking services in South Africa, rest of Africa, Europe, Asia, the United States, and internationally. The company operates through Nedbank Corporate and Investment Banking; Nedbank Business and Commercial Banking; Nedbank Personal and Private Banking; Nedbank Africa Regions; and Centre segments. It offers lending products, advisory services, leverage financing, trading, brokering, structuring, hedging, and client coverage; corporate finance advisory, ... [Read more]
Financial Performance
In 2025, Nedbank Group's revenue was 59.94 billion, a decrease of -7.77% compared to the previous year's 64.99 billion. Earnings were 7.80 billion, a decrease of -53.67%.
Financial StatementsNews
Nedbank Group Earnings Call Transcript: H2 2025
2025 saw modest earnings growth, strong capital and liquidity, and strategic moves including the ETI sale and new acquisitions. Outlook is positive with robust loan growth, digital momentum, and a focus on cost efficiency, but headwinds include lower rates and no ETI earnings.
Nedbank Group Transcript: Trading Update
Strong fee and commission growth in PPB and market share gains in secured lending offset slower CIB deal flow, with advances growth expected to accelerate in 2026. Capital and liquidity remain robust, and strategic initiatives like the iKhokha acquisition target SME and mass market expansion.
Nedbank Group Earnings Call Transcript: H1 2025
Diluted HEPS rose 7% and ROE improved to 15.2% in H1 2025, with strong capital and digital growth. ETI investment is now held for sale, and guidance for 2025 is more cautious amid macro headwinds, with a focus on cost control, digital, and capital optimization.
Nedbank Group Earnings Call Transcript: H2 2024
Diluted HEPS rose 11% and ROE reached 15.8% in 2024, driven by strong NIR growth, lower impairments, and cost control. Strategic initiatives and a major organizational restructure aim to boost long-term ROE above 18% amid a challenging macroeconomic environment.
Nedbank Group Earnings Call Transcript: H1 2024
Strong H1 2024 results with headline EPS up 12%, ROE at 15%, and an 11.5% dividend increase, driven by lower impairments and NIR growth. Outlook is cautiously optimistic, with improved macro conditions and a focus on further cost and capital efficiencies.